Initial Statement of Beneficial Ownership (3)
July 07 2022 - 3:37PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Anderson Glen R. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
6/27/2022
|
3. Issuer Name and Ticker or Trading Symbol
Indaptus Therapeutics, Inc. [INDP]
|
(Last)
(First)
(Middle)
101 SOUTH 200 EAST, SUITE 700 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director ___X___ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Street)
SALT LAKE CITY, UT 84111
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 113918 | D | |
Common Stock | 973130 (1) | I | By Anderson Family Trust u/a dtd 01/07/2018 |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | (1) On June 27, 2022, Reporting Person acquired 19,467 shares of common stock at $2.06 per share, resulting in total beneficial ownership as of June 27, 2022, of 844,970 shares of common stock or 10.23% of the outstanding common stock. Since June 27, 2022, Reporting Person has made the following purchases in the market: 61,360 shares at $2.22 per share on 6/28/2022; 57,620 shares at $2.39 per share on 6/29/2022; 79,400 shares at $2.99 per share on 7/1/2022; and 43,698 shares at $3.09 per share on 7/5/2022, for a total beneficial ownership of 1,087,048 shares of common stock as of July 5, 2022 or 13.16% of the outstanding common stock. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Anderson Glen R. 101 SOUTH 200 EAST, SUITE 700 SALT LAKE CITY, UT 84111 |
| X |
|
|
Signatures
|
Glen R. Anderson | | 7/7/2022 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Jul 2023 to Jul 2024